Coeptis Therapeutics Holdings Inc

For the period ended Jun 30, 2024. Filed Aug 16, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 16, 2024

ZSQR$2.30-17.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders' Equity (Deficit)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

For the Three and Six Months Ended June 30, 2024 and 2023

PREFERRED STOCK · COMMON STOCK · ADDITIONAL PAID-IN · SHARES · SUBSCRIPTION · ACCUMULATED · TOTAL COEPTIS · NON- CONTROLLING · TOTAL
	SHARES	AMOUNT	SHARES	AMOUNT	CAPITAL	SUBSCRIBED	RECEIVABLE	DEFICIT	EQUITY	INTERESTS	EQUITY
BALANCE AT DECEMBER 31, 2022	–	$–	19,566,839	$1,957	$70,541,095	$–	$–	$(66,089,723)	$4,453,329	$–	$4,453,329
Shares subscribed for non-employee services	–	–	1,374,197	137	2,396,677	720,000	–	–	3,116,814	–	3,116,814
Warrants issued for services	–	–	–	–	1,111,706	–	–		1,111,706	–	1,111,706
Stock based compensation	–	–	–	–	122,391	–	–	–	122,391	–	122,391
Net loss	–	–	–	–	–	–	–	(7,957,833)	(7,957,833)	–	(7,957,833)
BALANCE AT MARCH 31, 2023	–	$–	20,941,036	$2,094	$74,171,869	$720,000	$–	$(74,047,556)	$846,407	$–	$846,407
Shares subscribed for non-employee services	–	–	700,000	70	1,070,930	(720,000)	–	–	351,000	–	351,000
Warrants issued for services	–	–	–	–	811,500	–	–	–	811,500	–	811,500
Stock based compensation	–	–	–	–	113,301	–	–	–	113,301	–	113,301
Issuance of common stock and warrants, net of issuance costs	–	–	2,755,000	276	3,040,585	–	–	–	3,040,861	–	3,040,861
Net loss	–	–	–	–	–	–	–	(3,202,620)	(3,202,620)	–	(3,202,620)
BALANCE AT JUNE 30, 2023	–	$–	24,396,036	$2,440	$79,208,185	$–	$–	$(77,250,176)	$1,960,449	$–	$1,960,449

(continued)

PREFERRED STOCK · COMMON STOCK · ADDITIONAL PAID-IN · SHARES · SUBSCRIPTION · ACCUMULATED · TOTAL COEPTIS · NON- CONTROLLING · TOTAL
	SHARES	AMOUNT	SHARES	AMOUNT	CAPITAL	SUBSCRIBED	RECEIVABLE	DEFICIT	EQUITY	INTERESTS	EQUITY
BALANCE AT DECEMBER 31, 2023	–	$–	35,331,036	$3,533	$91,666,691	$–	$(3,500,000)	$(87,356,260)	$813,964	$–	$813,964
Shares issued for non-employee services	–	–	1,096,381	110	541,640	–	–	–	541,750	–	541,750
Warrants issued for cash	–	–	–	–	500,000	–	–	–	500,000	–	500,000
Warrants issued for services	–	–	–	–	8,150	–	–	–	8,150	–	8,150
Warrants issued in exchange for note receivable	–	–	–	–	1,900,000	–	(2,000,000)	–	(100,000)	–	(100,000)
Stock based compensation	–	–	–	–	96,889	–	–	–	96,889	–	96,889
Net loss	–	–	–	–	–	–	–	(3,001,388)	(3,001,388)	–	(3,001,388)
BALANCE AT MARCH 31, 2024	–	$–	36,427,417	$3,643	$94,713,370	$–	$(5,500,000)	$(90,357,648)	$(1,140,635)	$–	$(1,140,635)
Shares issued for services	–	–	1,850,000	185	558,165	–	–	–	558,350	–	558,350
Shares issued for the conversion of debt	506	1	1,441,176	144	951,855	–	–	–	952,000	–	952,000
Preferred share offering	3,794	1	–	–	3,661,505	50,000	(2,100,000)	–	1,611,506	132,494	1,744,000
Stock based compensation	–	–	–	–	611,570	–	–	–	611,570	–	611,570
Net loss	–	–	–	–	–	–	–	(3,035,345)	(3,035,345)	–	(3,035,345)
BALANCE AT JUNE 30, 2024	4,300	$2	39,718,593	$3,972	$100,496,465	$50,000	$(7,600,000)	$(93,392,993)	$(442,554)	$132,494	$(310,060)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.